[go: up one dir, main page]

SE404367B - Forfarande for framstellning av derivat av homofolsyra - Google Patents

Forfarande for framstellning av derivat av homofolsyra

Info

Publication number
SE404367B
SE404367B SE7307895A SE7307895A SE404367B SE 404367 B SE404367 B SE 404367B SE 7307895 A SE7307895 A SE 7307895A SE 7307895 A SE7307895 A SE 7307895A SE 404367 B SE404367 B SE 404367B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
acid derivatives
homofolic acid
homofolic
Prior art date
Application number
SE7307895A
Other languages
English (en)
Inventor
R L Knott
A Taunton-Rigby
Original Assignee
Us Health
Us Health Education & Welfare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health, Us Health Education & Welfare filed Critical Us Health
Publication of SE404367B publication Critical patent/SE404367B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7307895A 1972-06-16 1973-06-05 Forfarande for framstellning av derivat av homofolsyra SE404367B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US263559A US3870719A (en) 1972-06-16 1972-06-16 Synthesis of n-5-methyltetrahydrohomofolic acid and related reduced derivatives of homofolic acid

Publications (1)

Publication Number Publication Date
SE404367B true SE404367B (sv) 1978-10-02

Family

ID=23002269

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7307895A SE404367B (sv) 1972-06-16 1973-06-05 Forfarande for framstellning av derivat av homofolsyra

Country Status (19)

Country Link
US (2) US3870719A (sv)
JP (1) JPS5541234B2 (sv)
AT (1) AT329201B (sv)
AU (1) AU476569B2 (sv)
BE (1) BE801006A (sv)
CA (1) CA1004672A (sv)
CH (1) CH582178A5 (sv)
CS (1) CS169842B2 (sv)
DE (1) DE2330984A1 (sv)
DK (1) DK143028C (sv)
FR (1) FR2194708B1 (sv)
GB (1) GB1403850A (sv)
HU (1) HU166235B (sv)
NL (1) NL7307992A (sv)
NO (1) NO139890C (sv)
PL (1) PL89778B1 (sv)
RO (1) RO66639A (sv)
SE (1) SE404367B (sv)
YU (1) YU36958B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223500A (en) * 1977-02-22 1993-06-29 Bioresearch S.P.A. Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate
US5124452A (en) * 1978-07-10 1992-06-23 Bioresearch S.P.A. Process for producing d,1-5-methyltetrahydrofolic acid and its salts
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor
US4665176A (en) * 1984-10-23 1987-05-12 Mitsui Toatsu Chemicals, Incorporated Process for the preparation of 5,6,7,8-tetrahydrofolic acid
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2737515A (en) * 1951-06-30 1956-03-06 American Cyanamid Co Salts of substituted tetrahydroformyl pteroyl amino acids
US2790802A (en) * 1954-05-06 1957-04-30 American Cyanamid Co Substituted tetrahydropteridines and method of preparing the same
US3468886A (en) * 1967-10-23 1969-09-23 Us Health Education & Welfare Tetrahydrohomofolic acid sulfate and synthesis thereof

Also Published As

Publication number Publication date
AT329201B (de) 1976-04-26
JPS5541234B2 (sv) 1980-10-22
NO139890C (no) 1979-05-30
FR2194708A1 (sv) 1974-03-01
DE2330984A1 (de) 1974-01-03
CS169842B2 (sv) 1976-07-29
GB1403850A (en) 1975-08-28
US3983118A (en) 1976-09-28
YU36958B (en) 1984-08-31
US3870719A (en) 1975-03-11
AU5671873A (en) 1974-12-12
FR2194708B1 (sv) 1978-05-26
BE801006A (fr) 1973-10-01
DK143028C (da) 1981-11-02
NO139890B (no) 1979-02-19
NL7307992A (sv) 1973-12-18
CH582178A5 (sv) 1976-11-30
RO66639A (ro) 1982-05-10
CA1004672A (en) 1977-02-01
HU166235B (sv) 1975-02-28
DK143028B (da) 1981-03-16
ATA529073A (de) 1975-07-15
JPS4949992A (sv) 1974-05-15
YU158073A (en) 1982-06-18
PL89778B1 (sv) 1976-12-31
AU476569B2 (en) 1976-09-30

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE7611410L (sv) Forfarande for framstellning av nya derivat av penam-3-karboxylsyra
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE404367B (sv) Forfarande for framstellning av derivat av homofolsyra
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner